Researchers in The Lancet highlight coronary arterial inflammation’s role in increasing major adverse cardiac events and cardiovascular deaths, irrespective of coronary artery disease presence.
Phase 3 trial shows acoramidis safe and effective for transthyretin amyloid cardiomyopathy
Pumping over 100,000 times a day, the heart is a critical muscle needed to deliver oxygen and nutrients to our organs to sustain healthy bodily
January 17, 2024